A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Site HU36016, Budapest

Site DK45016, Copenhagen

Site DK45001, Herlev

Site DK45004, Gentofte Municipality

Site DK45002, Hillerød

Site ES34003, Palma de Mallorca

Site HU36012, Kaposvár

Site DK45007, Holsterbro

Site HU36007, Szigetvár

Site HU36017, Székesfehérvár

Site HU36002, Balatonfüred

Site DK45006, Viborg

Site IT39004, Turin

Site ES34007, Ciudad Real

Site DE49004, Berlin

Site IT39007, Bergamo

Site IT39005, Pavia

Site ES34006, Lugo

Site ES34008, Madrid

Site ES34012, Madrid

Site ES34010, Majadahonda

Site IT39002, Piacenza

Site DE49002, Düsseldorf

Site PL48001, Poznan

Site DE49003, Heidelberg

Site CZ42002, Brno

Site HU36005, Szikszó

Site PL48005, Sopot

Site CZ42003, České Budějovice

Site CZ42005, Prague

Site CZ42001, Prague

Site CZ42004, Prague

Site DE49008, Elsterwerda

Site HU36010, Budapest

Site HU36003, Hatvan

Site HU36018, Veszprém

Site IT39012, Rome

Site NL31004, Rotterdam

Site NL31001, Dordrecht

Site NL31003, Hoogeveen

Site PL48026, Lodz

Site PL48008, Lodz

Site PL48004, Lodz

Site PL48027, Oświęcim

Site PL48003, Płock

Site PL48022, Radom

Site PL48006, Rzeszów

Site PL48002, Torun

Site PL48025, Warsaw

Site ES34001, Barcelona

Site ES34005, Barcelona

Site ES34004, Barcelona

Site ES34002, Barcelona

Site GB44004, Burton-on-Trent

Site GB44001, Chester

Site GB44005, London

Site GB44003, South Yorkshire